BioMarin Pharmaceutical Inc., 770 Lindaro Street, San Rafael, CA (2026)

01/08/2026

Malachia Hoover, PhD is a postdoctoral research fellow on the Skeletal and CNP Research team in BioMarin’s Research & Early Development department. Her research explores how a protein called CNP helps bone-forming cells grow and strengthen bones. During her fellowship, Malachia is learning advanced lab techniques to study these cells, aiming to develop new ways to help people living with skeletal conditions build healthier bones. Her interest in this field began in graduate school, where she learned how stem cells contribute to spinal development.

“Malachia is conducting advanced research into CNP biology and our medicines, while also learning to navigate BioMarin and access our experts and technology,” says her manager Brett Crawford, who is Head of Musculoskeletal Research. “A postdoc at BioMarin provides immediate access to resources for research, unlike traditional academic labs where postdocs often spend significant time setting up their systems before starting research.”

Outside of research, Malachia, who earned her Ph.D. in Stem Cell Biology and Regenerative Medicine at Stanford University School of Medicine, loves baking and runs a small business called Brown Butta, which specializes in brown butter chocolate chip cookies.

Click the link to learn more about our postdoctoral fellowship programs: http://ms.spr.ly/6185tN1qD

01/06/2026

Meet Erica Iris Williams Ph.D., a postdoctoral fellow on the Neuroscience team in the Research & Early Development department at BioMarin. Her work focuses on developing innovative medicine delivery strategies targeted to the brain, with the aim of addressing neurological conditions. During her fellowship, Erica is not only advancing research in central nervous system delivery, but also gaining valuable experience in scientific strategy, contributing to BioMarin’s pipeline and portfolio development.

This multifaceted exposure positions her at the intersection of science and business, supporting her long-term goal to leverage her intellectual curiosity for broader patient impact within the biopharmaceutical industry. The BioMarin RED Fellowship provides Erica with tailored opportunities to blend her research with cross-functional experiences, thanks to the support from her research mentor and collaborators across the company.

“In her short time as a RED Fellow, Erica has made key contributions to new technology that could greatly expand our ability to deliver therapeutic molecules to hard-to-reach tissues,” says Justin Ichida, Erica’s manager and Head of Neuroscience Research. “Her enthusiasm, ideation, and ability to effectively integrate different teams has made Erica wonderful to work with.”

Erica, who earned a Ph.D. in Pharmacology from the University of Arizona, was originally inspired to pursue science as a child while attending Saturday science classes at Georgia State University. Outside of her professional pursuits, Erica enjoys exploring the culinary world, both by creating her own recipes and seeking out unique dining experiences.

Click the link to learn more about our postdoctoral fellowship programs: http://ms.spr.ly/6180tFQiQ

01/05/2026

Donnie Mackenzie, Analytical Lead on our Musculoskeletal Research team, has always been driven by a desire to solve problems, especially the ones that stand between patients and more hopeful futures.

For more than 15 years, Donnie has used this mindset to help BioMarin advance the science behind new medicines with the goal of making a profound impact on the lives of people living with rare genetic conditions.

Watch the latest edition of our Signature Science video series to see how Donnie’s problem-solving spirit is helping shape BioMarin’s breakthrough science.

Read more: http://ms.spr.ly/6186tFHdy

12/23/2025

As we near the end of a very busy 2025, we'd like to wish BioMarin employees a restful and well-earned break with loved ones. This has been a memorable year of connection and collaboration with patients, advocates and partners who helped advance our mission to make a profound impact for people living with rare genetic conditions. We're looking forward to another year of driving meaningful progress together in 2026.

12/22/2025

Meet Marie-Josee Toutounji. As the daughter of two chemists who worked in pharma, she grew up with the promise of medicine incorporated into her daily life. After initially dismissing the notion she would follow in her parents’ footsteps, Marie-Josee ended up becoming a pharmacist before expanding her impact with a rewarding career in biopharma.

In her role at BioMarin as the Medical Director of Canada, Marie-Josee leads all medical activities across the country, contributing to everything from approval and launch of new treatments to collaborating with regulatory partners, supporting clinical trials and engaging with patient communities and experts. Her commitment helps enable essential medicines to safely and compliantly reach those who need them most.

Read more about Marie-Josée's unexpected career journey to BioMarin: http://ms.spr.ly/6187tSZyW

12/18/2025

Jacob is a vibrant 11-year-old whose days are filled with running, jumping, dancing and an endless love for Mickey Mouse. He approaches life with curiosity and joy, especially when it comes to trying new foods.

Jacob is also living with (MPS) type IIIB, a rare genetic condition that affects approximately 1 in 70,000 children born in the United States. Also known as Sanfilippo syndrome, III is a progressive condition with no approved treatments that leads to a decline in cognitive abilities, loss of motor skills, musculoskeletal issues and, ultimately, premature death before children reach adulthood.

Jacob was initially diagnosed with autism and an unspecified developmental disability at a young age. However, his mother, Jennifer, always had a feeling that there was something more going on.

After years of advocating for answers, a genetic test finally revealed Jacob’s MPS IIIB diagnosis in late 2024.

Jacob’s diagnosis led Jennifer to the National MPS Society, which quickly connected her with the Cure Sanfilippo Foundation and helped guide her on next steps, even sending a team member to join the family for Jacob’s first appointment with a genetic specialist.

Life with Sanfilippo brings ongoing challenges, particularly developmental regression and the need for constant care.

“He has lost so much because of Sanfilippo,” says Jennifer. “When he was younger, I could take him anywhere and he was present. Now, he’s in his own world.”

Still, there are bright spots. Jacob now attends a specialized school where he receives one-on-one care tailored to his needs, which Jennifer says has helped slow his regression.

Through the MPS community, Jennifer also connected with a family near their home in Connecticut whose daughter shares Jacob’s diagnosis. The children became friends, and that bond has been a source of comfort.

At home, Jennifer shares a deep bond with Jacob.

“We have a nonverbal connection so I kind of just figure out what he needs at any point.” she says.

Beyond caring for Jacob and his 6-year-old brother, Cameron, Jennifer’s life is centered around awareness and hope. She wants Jacob to live a long life and help others with Sanfilippo. As someone who has dedicated her own career to helping people of all ages with disabilities, Jennifer has made it her mission to educate Jacob’s doctors, and anyone who will listen, about his condition so they can help others in the future.

“I truly believe I was given Jacob for a reason,” Jennifer says. “I want these doctors to be able to save someone when they see the same thing in the future.”

Read more about Jacob’s story on the National MPS Society website: http://ms.spr.ly/6183tob1v

12/16/2025

Jose Uribe Salazar is a postdoctoral research fellow on the Gene Editing team in BioMarin’s Research & Early Development department. His research centers on discovering new therapeutic targets and testing them in vitro to identify promising candidates for further study. During his fellowship, Jose has focused on mastering large-scale gene editing and genomic screening techniques, which will enable him to evaluate thousands of genetic regions simultaneously.

“Jose exemplifies the BioMarin 8 operating principles by bringing patient-focused urgency and a collaborative spirit to every discussion, working cross-functionally to unite diverse teams and functional experts in translating innovative functional genomics research into potential new therapies for genetic conditions,” says Steven Froelich, Jose’s manager and Head of Gene Editing.

Jose's passion for the field was ignited by a deep curiosity about human diversity and a fascination with DNA and gene-editing technologies, which ultimately led to him earning his Ph.D. in Integrative Genetics and Genomics from the University of California, Davis.

Outside the lab, Jose enjoys outdoor activities such as camping, hiking, biking and spending time with his two young children.

Click the link to learn more about our postdoctoral fellowship programs and learn how to apply:
http://ms.spr.ly/6180tm4du

12/09/2025

Global leaders from BioMarin’s nine Employee Resource Groups (ERG) came together last week at our San Rafael headquarters to connect, learn from one another and celebrate the significant impact employees made this year. From sustainability toolkits to intersectional programming, teams demonstrated how local ideas scale globally while reinforcing the meaningful contributions of our .

A “Gallery of Success” shared 2025 highlights, including rapid membership growth, community donations and cross‑ERG collaborations that expanded education, allyship and volunteerism.

Thank you to all who joined the summit, and to all of our ERG leaders, members and allies for the energy and dedication you bring to creating a culture of .

12/08/2025

BioMarin’s postdoctoral fellowship programs in our Regulatory Affairs and Research & Early Development (RED) departments provide early-career scientists and emerging biopharma professionals with valuable industry experience and opportunities for meaningful career development. Fellows collaborate with our scientific teams to support the development of new medicines for genetic conditions, bringing fresh perspectives and helping promote mutual learning.

The Regulatory Affairs Fellowship program includes two years of immersive rotations at Howard University and BioMarin, providing valuable training in regulatory science, research methods, and law and policy education. Fellows gain practical teaching experience and are offered Project Management Professional (PMP)® and Regulatory Affairs Professional Society (RAPS) certification preparation.

The RED Fellowship program offers two years dedicated to innovative genetic research and medicine development, with fellows spending 80% of their time on research projects, supported by expert mentors, with opportunities to contribute to publications and strategic initiatives.

Over the coming weeks, we will be highlighting the individuals in our current cohort – Malachia Hoover, Erica Williams, Jose Uribe Salazar and Sulin Kamt. Check back to learn more about their experiences and how they hope to make an impact in our industry.

Read more about our postdoctoral fellowship programs and learn how to apply: http://ms.spr.ly/6182tg4Xr

12/04/2025

BioMarin’s postdoctoral fellowship programs in our Regulatory Affairs and Research & Early Development (RED) departments provide early-career scientists and emerging biopharma professionals with valuable industry experience and opportunities for meaningful career development. Fellows collaborate with our scientific teams to support the development of new medicines for genetic conditions, bringing fresh perspectives and helping promote mutual learning.

The Regulatory Affairs Fellowship program includes two years of immersive rotations at Howard University and BioMarin, providing valuable training in regulatory science, research methods, and law and policy education. Fellows gain practical teaching experience and are offered Project Management Professional (PMP)® and Regulatory Affairs Professional Society (RAPS) certification preparation.

The RED Fellowship program offers two years dedicated to innovative genetic research and medicine development, with fellows spending 80% of their time on research projects, supported by expert mentors, with opportunities to contribute to publications and strategic initiatives.

Over the coming weeks, we will be highlighting the individuals in our current cohort – Malachia Hoover, Erica Williams, Jose Uribe Salazar and Sulin Kamt. Check back to learn more about their experiences and how they hope to make an impact in our industry.

Read more about our postdoctoral fellowship programs and learn how to apply: http://ms.spr.ly/6185tePdx

12/03/2025

We’re reflecting on a memorable year with the PKU community as we recognize National . We “moved our Pheet” with the National PKU Alliance, went to summer camp with flok and enjoyed a number of opportunities to connect with, support and amplify the voices of people living with .

Each connection, story and celebration reminds us of the resilience of this community, as well as the challenges people living with PKU can face. We look forward to continuing to build meaningful relationships in the years to come as we work together to improve the lives of those with PKU.

12/02/2025

Joyanna Hansen has always been fascinated by the connection between genetics and nutrition, a passion that’s shaped her work in inherited metabolic conditions.

She began her career as a registered dietitian, working directly with people living with phenylketonuria (PKU). Today, as a Medical Science Liaison on BioMarin’s Global Medical Affairs team, Joyanna partners closely with clinicians and the community to advance understanding and care.

In the third edition of our Signature Science video series, Joyanna shares how her clinical background shapes her work, and how she’s putting her own signature on BioMarin’s breakthrough science.

Read more: http://ms.spr.ly/6187tjwDZ

BioMarin Pharmaceutical Inc.